Os glicocorticoides (GC) são prescritos por praticamente todas as especialidades médicas,
e cerca de 0, 5% da população geral do Reino Unido utiliza esses medicamentos. Com o …

OBJECTIVE: To compare bone density with polymorphisms in the calcitonin receptor (CTR)
and vitamin D receptor (VDR) genes in 50 patients with juvenile idiopathic arthritis and 80 …

Metabolic bone disease in children includes many hereditary and acquired conditions of
diverse etiology that lead to disturbed metabolism of the bone tissue. Some of these …

The objective of this study was to determine the impact of glucocorticoid exposure on lumbar
spine bone mineral density (BMD) in children while concurrently measuring their calcium …

OBJECTIVE: Alendronate treatment for 12 months in pediatric patients with rheumatic
diseases and secondary low bone mass was reported to result in a substantial increase in …

Objectives: To describe an attempted interventional trial for glucocorticoid‐induced
osteoporosis in children and adolescents and to discuss the reasons for trial failure to inform …

Osteoporosis may affect young individuals, albeit infrequently. In childhood, bone mass
increases, reaching its peak between the second and third decades; then, after a period of …

The optimal treatment of children with rheumatic diseases is often different from analogous
conditions of adults. Firstly, the disease processes might be different, with different outcomes …

OBJECTIVE: To evaluate at baseline and after one year the bone status in children with
chronic rheumatic diseases (CRD) using quantitative ultrasound techniques. METHODS: We …

Chronic idiopathic hyperphosphatasia (CIH), or juvenile Paget disease, is a rare disorder
characterized by increased bone turnover and progressive enlargement of bones. We report …